Full Approval Of Sotorasib News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA has issued a complete response letter to the supplemental new drug application seeking the full approval of sotorasib for patients with KRAS G12C–mutated non–small cell lung cancer.

United statesFull approval of sotorasibPatients with kras g12c mutated non small cell lung cancerCodebreak 200 trialCodebreak 100 trial